cancer – Page 2 – media

Two Antipsychotic Drugs Destroy Cancer Cells

Based on studies that have revealed how specific malignancies thrive on cholesterol, and that raised serum cholesterol levels are linked to the risk of cancer and a drug compound called leelamine that has shown to retard tumor-growth in melanoma...
- Source: MedicalNewsToday
- 674
- August 1, 2018
antipsychotics cancer Researches
Endomag Breast Cancer Device Gains FDA Approval

Endomag received premarket approval from the FDA for Magtrace, the novel non-radioactive dual-tracer for lymphatic plotting in breast cancer patients which facilitates the implementation of magnetic detection during sentinel lymph node biopsy procedures to spot sentinel lymph nodes for surgical excision.
- Source: The Verdict
- 786
- August 1, 2018
cancer FDA medical device New Approvals
Blood Test to Suggest Best Possible Treatment for Advanced Prostate Cancer

Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences conducted an international mutual study which discovered a novel blood test that can foresee advanced prostate cancer patient response to particular treatments, resulting in better survival.
- Source: ScienceDaily
- 803
- July 26, 2018
blood test cancer prostate cancer Researches
Valsartan Based Drugs Recalled by FDA

At the beginning of this month, the U.S. Food and Drug Administration (FDA) announced to withdraw drugs containing valsartan, which treat high blood pressure and heart failure. The drugs were withdrawn due to the presence of N-nitrosodimethylamine (NDMA), which might lead to cancer.
- Source: HealthLine
- 871
- July 26, 2018
blood pressure cancer FDA heart failure Policies
Mersana’s Lead Cancer ADC Held Up by FDA for Patient’s Death

The FDA held up Mersana’s top antibody-drug conjugate (ADC), XMT-1522 over safety issues following a patient’s death in phase 1 trial, causing a descent in the company’s shares.
- Source: FierceBiotech
- 200
- July 25, 2018
cancer Clinical Trial FDA
Karyopharm Seeks FDA Approval for Selinexor Drug for Multiple Myeloma

The Newton Massachusetts-based company, Karyopharm Therapeutics, who developed a new class of drugs to treat multiple myeloma, is in the process of submitting a new drug application to the FDA for their selinexor drug.
- Source: MedCityNews
- 411
- July 24, 2018
cancer CAR-T therapies FDA New Approvals
Study Unravels New Protein Complex that Repairs Broken DNA Ends

In a major breakthrough in cancer research, a team of scientists from the University of Toronto, The Institute of Cancer Research, London, The Netherlands Cancer Institute and the University of Bern have discovered how cells repair damaged strands of DNA. They revealed a brand new protein complex in cells that protect broken DNA ends and causes its repair, in their study published in Nature on Wednesday.
- Source: News Medical
- 826
- July 23, 2018
cancer DNA Researches
Magnetic Wire Detects Cancer Cells in Flowing Blood

Stanford University School of Medicine Researchers have developed a magnetic wire that catches tumor cells flowing in the bloodstream. The wire, inserted into a vein, captures even limited tumor cells, ushering in a new means to detect cancer early.
- Source: The Verdict
- 606
- July 21, 2018
cancer Researches
New Molecule Designed to Fight Cancer

University of Adelaide researchers have designed a new molecule which targets a protein essential to the growth of most cancers. The protein target is called proliferating cell nuclear antigen (PCNA), also known as the human sliding clamp.
- Source: ScienceDaily
- 752
- July 19, 2018
anticancer cancer Researches
Hidden Blood in Stool Could Predict Fatal Health Conditions

If a drop of blood is seen in stool, people tend to panic. The causative factors could include digestive, respiratory, circulatory, hematological or even neuropsychological diseases.
- Source: MedicalXpress
- 693
- July 18, 2018
bowel cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.